Search Results For :: patient flow

• Cold Flow Improvers Market by Type (Ethylene Vinyl Acetate, Polyalpha Olefin, Polyalkyl Methacrylate), Application (Diesel Fuel, Lubricating Oil, Aviation Fuel), End-Use Industry (Automotive, Aerospace & Defense) and Region - Global Forecast 2023

  The cold flow improvers market size is projected to grow from USD 605 million in 2018 to USD 806 million by 2023, at a CAGR of 5.9%. Cold flow improvers are polymers or co-polymers additive which prevent the formation of crystals in fuel or lubricating oil which can clog the filters and feed lines at low temperature and cause engine shutdown. They are generally used in fuel and lubricating oil.Lubrizol Corporation (US), Chevron Oronite (US), Clariant AG (Switzerland), Afton Chemicals (US), BASF SE (Germany), Innospec (US), Evonik Industries AG (Germany), Infineum International Limited (UK), and Baker Hughes (US).

  • Published: April 2019
  • Price: $ 4950
  • TOC Available:

• Flow Chemistry Market by reactor (Tabular Reactors, Microreactors, Oscillatory Flow Rectors, Droplet-Based Reactors, Photochemical Reactors), Purification Method( Chromatography, Liquid-Liquid Extraction), Application, & Region - Global Forecast 2028

  The global Flow Chemistry market is expected to grow at a CAGR of 10.4% during the forecast period, from an estimated USD 1.7 billion in 2023 to USD 2.9 billion in 2028. Chemical synthesis is one of the major applications of the flow chemistry market and offers market growth opportunities. The Tabular reactor by reactor segment is experiencing high growth rates in emerging regions such as Asia Pacific and North America.

  • Published: June 2023
  • Price: $ 4950
  • TOC Available:

• Patient Access Solutions Market by Product & Service (Training, Education, Medical Necessity, Pre-certification), Delivery Mode (Web & Cloud, On premise), End User (Providers, Healthcare BPO Service Providers) - Global Forecast to 2027

  The global patient access solutions market is primed to transition from $1.9 billion in 2022 to $2.9 billion by 2027, showcasing a strong CAGR of 8.9%. The factors driving market growth include the need to maintain regulatory compliance, rising need to curtail healthcare costs, rising importance of denials management. However, dearth of skilled IT professionals, and high deployment costs is challenging the growth of the global patient access solutions market to a certain extent.

  • Published: August 2022
  • Price: $ 4950
  • TOC Available:

• Patient Monitoring Devices – Emerging Markets BRIC(Brazil, Russia, India, China) 2010-2015

  The Emerging Markets: BRIC (Brazil, Russia, India and China) Patient Monitors witnesses significant growth opportunities due to rapidly aging population, high incidence of chronic diseases, and government initiatives such as reform in healthcare delivery systems. Despite the impact of economic slowdown, BRIC nations are expected to grow at a CAGR of around 10 - 12% from 2009 – 2014.

  • Published: July 2010
  • Price: $ 4950
  • TOC Available:

• Patient Monitoring Devices Market by Product (Multiparameter, Glucose CGM, Wearables, EEG, EMG, ECG, ILR, MCT, Pulse Oximeter, Fetal, Neonatal, BP, Hemodynamic, Spirometer, Capnograph), End User (Hospital, ICU, ASC), & Region - Global Forecast to 2031

  The global patient monitoring devices market is projected to reach USD 76.11 billion by 2031, growing at a CAGR of 6.4% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.

  • Published: June 2026
  • Price: $ 4950
  • TOC Available:

• Bio-Implants Market - by Type (Cardiovascular, Spine, Orthopedics, Trauma, Dental), by ROA (Surgical/Injectable), by Origin (Allo/Auto/Xenograft, Synthetic) & Materials (Ceramics, Biomaterial, Alloys, Polymers) - Global Trends &, Forecasts till 2017

  Bio-implants can be defined as prostheses used to regularize physiological functions. They are made up of biosynthetic materials like collagen, and tissue-engineered products like artificial skin or tissues. Most bioengineered products like cardiac pacemakers and orthopedic artificial implants are also covered under bio-implants, since they are implanted entirely in the patient’s body.

  • Published: September 2012
  • Price: $ 4950
  • TOC Available:

• Heat Exchanger Market by Type (Shell & Tube, Plate & Frame, Air Cooled), Material (Metals, Alloys, Brazing Clad Materials), End-use Industry (Chemical, Energy, HVACR, Food & Beverage, Power, Pulp & Paper), and Region - Global Forecast to 2030

  The heat exchanger market is expected to grow from USD 23.95 billion in 2025 to USD 33.52 billion by 2030, at a CAGR of 7.0% during the forecast period. The heat exchanger market comprises key manufacturers such as Alfa Laval (Sweden), Kelvion Holding GmbH (Germany), Danfoss (Denmark), Exchanger Industries Limited (Canada), Mersen (France), API Heat Transfer (US), BOYD (US), Johnson Controls (Ireland), Xylem (US), Wabtec Corporation (US) ,SPX Flow (US), Lennox International Inc. (US), Modine Manufacturing Company (US), Wieland (Germany) and Air Products & Chemicals, Inc. (US), among others.

  • Published: September 2025
  • Price: $ 4950
  • TOC Available:

• Data Center Fabric Market by Solutions (Switching, Routers, Controllers, SAN, Network Security Equipments, Management Software) & User Environment (Enterprises, Telecommunications, Cloud Providers) - Worldwide Forecasts & Analysis (2014 - 2019)

  Continuously developing next-generation enterprise Information Technology (IT) architecture for data centers is enhancing the adoption and utilization of fabric in the data centers. Data center fabric is emerging as a solution to meet the networking demands for virtual and cloud environments in new data centers. Fabric network reduces the tiers in the legacy network architecture, providing agility, flexibility and efficiency in operations. The traditional network is not efficient in handling east-west flow of data among servers due to virtualization of data centers. Fabric provides relatively simple network architecture than the three-tiered network, and helps in utilizing the advantages of new technologies such as virtual machines and cloud storage to the fullest.

  • Published: April 2014
  • Price: $ 4950
  • TOC Available:

• Optical Imaging Market by Product (Cameras, Lenses), Technique (OCT, HIS, NIR, PAT), Therapeutic Area (Ophthalmology, Dermatology, Oncology), Application (Pathological, Intraoperative), End User (Hospital, Research Labs) & Region - Global Forecast to 2027

  The global optical Imaging market growth is primed to transition from USD 1.5 billion in 2022 to USD 2.9 billion by 2027, showcasing a strong CAGR of 13.5%. Precise differentiation between soft tissues and affected tissues, reduced patient exposure to eradicating radiations, increased prevalence of age related macular degeneration, increased GDP expenditure on healthcare among rapidly growing economies, increased need and adoption of non invasive tools for rapid scanning and identification of disorders coupled with increasing research to adopt these tools in the field of dentistry, gastroenterology, and gynecology are factors influencing the market growth and adoption of optical imaging systems.

  • Published: February 2023
  • Price: $ 4950
  • TOC Available:

• North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017

  The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.

  • Published: April 2013
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS
• NEXT
• LAST

Records 21 to 30 of 60